Skip to content

A Multicenter Randomized Controlled Clinical Trial of Nonsteroidal Anti-Inflammatory Drugs for Preemptive Analgesia in Mandibular Impacted Third Molar Extraction

A Multicenter Randomized Controlled Clinical Trial of Nonsteroidal Anti-Inflammatory Drugs for Preemptive Analgesia in Mandibular Impacted Third Molar Extraction

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200057962
Enrollment
Unknown
Registered
2022-03-24
Start date
2022-04-01
Completion date
Unknown
Last updated
2023-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mandibular Impacted Third Molar

Interventions

Test group:One Ibuprofen Sustained-Release Capsule will be taken orally 15 minutes before operation

Sponsors

Beijing Stomatological Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. The age is between 18-50 years old; 2. No history of cardiopulmonary disease, liver and kidney disease, abnormal bleeding, and abnormal coagulation function; 3. No analgesic, anti-inflammatory, and anticoagulant drugs were taken 1 week before tooth extraction; 4. Mandibular median mesial impacted third molars in Pell and Gregory classification; 5. The operation is expected to be completed within 15-30 minutes; 6. Patients are willing to participate in this study and fill in the questionnaire.

Exclusion criteria

Exclusion criteria: 1. Pregnant, physiological or lactating women; 2. Combined with acute oral infectious diseases or tumors. 3. Allergic reaction to the drug used in this study; 4.Suffering from chronic pulpitis, chronic periapical periodontitis, trigeminal neuralgia, glossopharyngeal neuralgia and other pain diseases without treatment or requiring long-term use of other painkillers; 5. The patient drank alcohol within one week before operation; 6. Patients with previous history of upper gastrointestinal bleeding or perforation related to the use of nonsteroidal anti-inflammatory drugs; 7. Patients with active or previous history of peptic ulcer, gastrointestinal bleeding or perforation; 8. Allergic to other non steroidal anti-inflammatory drugs; 9. Asthmatic patients allergic to aspirin; 10. Taking other anti-inflammatory drugs containing ibuprofen or other non steroidal drugs, including drugs known to be specific cyclooxygenase-2 inhibitors; 11. Patients with intellectual, visual, hearing or communication impairment or other patients considered by the investigator to be unsuitable to participate in the trial.

Design outcomes

Primary

MeasureTime frame
VAS score;

Secondary

MeasureTime frame
score of Dental Fear Survey (DFS);score of Stouthard's Dental Anxiety Inventory( DAI);Dosage and duration of postoperative analgesics;VAS score;

Countries

China

Contacts

Public ContactZhou Jian

Beijing Stomatological Hospital, Capital Medical University

Zhoujian5010@hotmail.com+86 13401180051

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026